Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340701 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Progesterone in Pregnancy
A Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03340701 is a Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 6 participants.
The verdict
NCT03340701, a Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation
Interventions
- DRUG vaginal progesterone suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2018-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340701
The ClinicalTrials.gov registry entry for NCT03340701 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vaginal progesterone suppository is the first listed.
NCT03340701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03340701 about?
NCT03340701 is a clinical study titled "Pharmacokinetics of Progesterone in Pregnancy". Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation
What is the current status of trial NCT03340701?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-11-06. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03340701?
The interventions under investigation include: vaginal progesterone suppository (DRUG).
Who is sponsoring clinical trial NCT03340701?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.